Journal of the European Academy of Dermatology and Venereology

Papers
(The H4-Index of Journal of the European Academy of Dermatology and Venereology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Editor's Picks290
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser195
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin183
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic162
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens158
Are non‐fungible tokens the barrier to realizing the Dermoverse?144
Announcement124
Announcement96
Editor's Picks January 202488
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort85
Announcement81
Issue Information78
Peer review, scientific publishing and the law of reciprocity73
72
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti70
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin66
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment65
Two cases of cerebrovascular accidents following the induction dose of risankizumab63
Chat GPT in dermatology: Progressive or problematic?62
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer61
Efficacy of imiquimod in the management of lentigo maligna60
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV56
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review53
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis53
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations52
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa51
Systemic neurokinin‐1 receptor antagonists mitigate chronic pruritus: A systematic review and meta‐analysis51
Louis Adolphus Duhring: An enduring legacy51
Dupilumab for the treatment of refractory allergic contact dermatitis from rubber/latex concomitant with atopic dermatitis48
Real‐world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single‐centre, prospective, open‐label study48
Issue Information45
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization44
Announcement44
44
Dalbavancin for the treatment of severe hidradenitis suppurativa43
Announcement43
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use43
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report42
The chicken or the egg of lymphopenia in atopic eczema42
A case of eruptive halo nevi following COVID‐1942
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study41
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–201941
The future of digital pills and their potential use in dermatological clinical trials41
Pharmacovigilance: The responsibility of all41
2.0645599365234